Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)

4.54
Delayed Data
As of Jun 28
 0.00 / 0.00%
Today’s Change
3.50
Today|||52-Week Range
10.94
-40.34%
Year-to-Date
No recent news for Galmed Pharmaceuticals Ltd.

Today’s Trading

Previous close4.54
Today’s openn.a.
Day’s range-- - --
Volume0
Average volume (3 months)33,140
Market cap$50.4M
Dividend yield--
Data as of 06/28/2016

Growth & Valuation

Earnings growth (last year)-9.09%
Earnings growth (this year)-51.67%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book2.34

Competitors

 Today’s
change
Today’s
% change
IMMYImprimis Pharmaceuti...0.000.00%
NTECIntec Pharma Ltd0.000.00%
SCYXSCYNEXIS Inc-0.05-2.25%
AXNAoxing Pharmaceutica...+0.01+1.09%
Data as of 10:17am ET, 06/29/2016

Financials

Next reporting dateJuly 22, 2016
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$0.00
Annual profit (last year)-$10.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO &
Class II Director
Allen Baharaff
Chief Financial Officer
Josh Blacher
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

Partner Offers

Search for Jobs